US 11471449
Use of pridopidine to improve cognitive function and for treating Alzheimer's disease
granted A61KA61K31/451A61K45/06
Quick answer
US patent 11471449 (Use of pridopidine to improve cognitive function and for treating Alzheimer's disease) held by The Board of Regents of the University of Texas System expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/451, A61K45/06, A61P, A61P25/08